Both traumatic and non‐traumatic spinal cord injuries (SCIs) can be categorized as
damages done to our central nervous system (CNS). The patients' physical and mental …

The use of mesenchymal stem/stromal cells (MSCs) for transplant-mediated repair
represents an important and promising therapeutic strategy after spinal cord injury (SCI) …

Currently, there is no cure for traumatic spinal cord injury but one therapeutic approach
showing promise is gene therapy. In this systematic review and meta-analysis, we aim to …

Spinal cord regeneration is limited due to various obstacles and complex pathophysiological
events after injury. Combination therapy is one approach that recently garnered attention for …

Degenerative cervical myelopathy (DCM) is the most prevalent cause of spinal cord
dysfunction in the aging population. Significant neurological deficits may result from a …

The ability to reliably repair spinal cord injuries (SCI) will be one of the greatest human
achievements realized in regenerative medicine. Until recently, the cellular path to this goal …

Spinal cord injury (SCI) is a devastating traumatic injury often causing permanent loss of
function. The challenge of treating SCI stems from the development of a complex …

Background Traumatic spinal cord injury (SCI) is a serious disorder that results in severe
impairment of neurological function as well as disability, ultimately reducing a patient's …

Current therapeutic strategies for spinal cord injury (SCI) cannot fully facilitate neural
regeneration or improve function. Arginine decarboxylase (ADC) synthesizes agmatine, an …

Spinal cord injury (SCI) is a severe and traumatic disorder that ultimately results in the loss
of motor, sensory, and autonomic nervous function. After SCI, local immune inflammatory …